Scientific Research News
News about theoretical and practical scientific research spanning a wide variety of disciplines, including engineering, computer science, biology, physics and chemistry. Includes information about research facilities, funding, resources and public policy.
The Retreat Announces the Curtis Carlson Nelson Research Institute to Focus on Addiction and Recovery Research, Advocacy
The Retreat is announcing The Curtis Carlson Nelson Research Institute at The Retreat. Created to honor the legacy of longtime friend Curtis Carlson Nelson, it will focus on research and advocacy into substance abuse and recovery. The first project will study outcomes for Twelve Step, abstinence- and community-based recovery models. The research will be conducted by Dr. John Kelly of Harvard Medical School, Massachusetts General Hospital and the Recovery Research Institute. - February 02, 2023 - The Retreat
The Area 51 First Contact Research Center Documents Improved Instrument Resolution Bandwidth & Sensitivity Settings for Advance Life Form Studies
The Area 51 First Contact Research Center investigators, using industry leading electromagnetic spectrum analyzers, determined -120 dBm as a new instrument sensitivity setting for working with sources of Area 51 Advanced Life Form evidence. The new instrument resolution bandwidth requirement was... - February 01, 2023 - Area 51 First Contact Research Center
New Book from The Oaklea Press Climbs to “Number One New Release” in Two-Hour Science and Math Short Reads
“Proof Mind Creates Matter,” a book recently released that reports on quantum physics experiments and other research has topped the new release bestseller chart on Amazon for two-hour science and math reads. - January 23, 2023 - The Oaklea Press
The Canadian College of Naturopathic Medicine and Southern Cross University of Australia Announce Collaboration
International collaboration highlights reach and depth of naturopathic education around the world. The Canadian College of Naturopathic Medicine (CCNM) and the National Centre for Naturopathic Medicine at Southern Cross University (SCU), Australia have signed a memorandum of understanding (MOU)... - January 19, 2023 - Canadian College of Naturopathic Medicine
Huntington Study Group Names First Chief Innovation Officer
The Huntington Study Group (HSG), a world leader in clinical research for Huntington’s Disease (HD) for over 30 years, today announced Brett Kinsler has been named to the newly created position of Chief Innovation Officer (CINO). - January 10, 2023 - Huntington Study Group
Creative Diagnostics Introduces New Hemagglutination Inhibition Assay Services
Creative Diagnostics recently introduced Hemagglutination Inhibition Assay services to determine relative concentrations of viruses, bacteria, or antibodies. - January 06, 2023 - Creative Diagnostics
Creative Diagnostics Introduces Plaque Reduction Assay Service for Research Applications
Creative Diagnostics recently introduced Plaque Reduction Assay services to detect antibodies from testing serum and viruses within diseased materials to diagnose viral infectious diseases. - December 28, 2022 - Creative Diagnostics
PharmStars Announces Fall 2022 Accelerator Graduates: 11 Digital Health Startups Complete PharmStars’ Pharma-Focused Accelerator Program
PharmStars, the pharma-focused accelerator for digital health startups, announces the graduation of 11 startups from its Fall 2022 program focused on “Innovations in Real-World Evidence.” The graduating startups successfully completed PharmaU, PharmStars’ 10-week education, and mentoring program. PharmaU culminated with a Showcase Event--held in Boston in early November--that brought together the participating startups and PharmStars’ seven innovation-minded pharma members. - December 08, 2022 - PharmStars
PharmStars Announces “Innovations in Women’s Health and Health Equity” Theme for Spring 2023 Accelerator
PharmStars, the pharma-focused accelerator for digital health startups, is now accepting applications for its Spring 2023 cohort with the theme “Digital Innovations in Women’s Health and Health Equity.” Startups with digital innovations that promote more equitable, inclusive healthcare for underserved population or focused on women’s health (e.g., breast, ovarian, and cervical cancer; gynecological conditions; osteoporosis; menopausal, hormonal, and reproductive conditions) are welcome to apply. - December 05, 2022 - PharmStars
UserWise, LLC Launches Its First eLearning Catalog
UserWise, LLC, a San Jose, California-based Human Factors consultancy, has launched UserWise University, another step towards helping develop safe and usable medical devices. - December 01, 2022 - UserWise, LLC
Creative Diagnostics Introduces Hemagglutination Assay Service for Scientific Applications
Creative Diagnostics recently introduced Hemagglutination Assay services for influenza vaccine, diagnostic, and surveillance communities to measure virus and antibody titers and monitor influenza subtypes. - November 26, 2022 - Creative Diagnostics
Resoptima Partners with Aker BP, Sval Energi, and NORCE to Reduce CO2 Emissions for Oil and Gas Production
Resoptima announced today a joint project with the support of the Research Council of Norway. The partnership includes Aker BP and Sval Energi as E&P operators and NORCE as an independent research institute. The project aims at leveraging Resoptima’s reservoir modelling and reservoir management technologies to further develop specific solutions that will help reduce CO2 emissions associated with oil and gas asset development and production activities. - November 17, 2022 - Resoptima
Are You Ready to Get Shroomed?
After a historical win for the war on drugs in Colorado, the state and the nation begins to look at ways to implement Magic Mushroom assisted therapy along with other plant medicine. We look at the facts behind this, and what it means for you. - November 11, 2022 - shroomed
DataJoint Launches New Cloud-Based System for Automating Neuroscience Experiments
DataJoint's New Cloud Solution Improves Lab Efficiency and Accuracy - November 11, 2022 - DataJoint
PharmStars Announces Fall 2022 Startup Showcase Event
PharmStars, the pharma-focused accelerator for digital health startups, announces that its Fall 2022 Showcase Event will begin on November 8, 2022. The Showcase is the culmination of a 10-week startup accelerator program. At the Showcase Event, startups will make formal presentations to and meet... - November 08, 2022 - PharmStars
Biomed Industries, Inc. (“Biomed”) Today Announced the Closing of Its Merger with MedAware Systems, Inc., (“MedAware”)
Biomed Industries, Inc. (“Biomed”) today announced the closing of its merger with MedAware Systems, Inc., (“MedAware”), in which all issued and outstanding common shares of capital stock of MedAware will be exchanged for common stock of Biomed at a ratio of 5.33 shares of MedAware for 1 new common share of Biomed. The transaction valued at an aggregate of $20 million, to be paid by 2,259,170 common shares of Biomed. At present, Biomed has approximately 76,354,075 common shares issued. - November 07, 2022 - Biomed Industries, Inc.
New Pivotal Data Demonstrates Clinical Feasibility of GeneFluidics’ Direct-from-Specimen AST in Clinical Settings
GeneFluidics, Inc. is pleased to announce a joint publication with the Medical College of Wisconsin (MCW) that introduces rapid antimicrobial susceptibility testing (AST), which would represent a paradigm shift in the clinical management of microbial infections. The data from the MCW study have... - November 04, 2022 - GeneFluidics Inc.
Introducing Wholeview Direct: Delivering Addiction Treatment Directly Into the Homes of New Yorkers
Wholeview Direct, a new, fully virtual, outpatient addiction treatment program has begun to provide treatment throughout the State of New York. - November 01, 2022 - Wholeview Wellness
DistillerSR Launches New CuratorCR Capabilities to More Dynamically Manage and Reuse Evidence-Based Research
CuratorCR Knowledge Center Provides Alternative to Elsevier’s QUOSA Virtual Library as Its Sunset Date Looms. - October 31, 2022 - DistillerSR
UTECH® Products Expands Operations to Abu Dhabi, Totaling Eight International Offices
UTECH® Products Inc., a medical and laboratory equipment and supplies company is pleased to announce expanding operations to Abu Dhabi, United Arab Emirates, making it its 8th office worldwide. UTECH is bringing its expansive offerings to the Middle East market as a global leader in medical... - October 25, 2022 - EndoSoft
ASTER Labs, Inc. Awarded SpaceWERX Orbital Prime Contract
ASTER Labs, Inc. has been awarded a STTR Phase I under the SpaceWERX Orbital Prime Program. - October 23, 2022 - ASTER Labs Inc.
Creative Diagnostics Introduces Fluorometric Neuraminidase Assay Service for High-Throughput Discovery
As an expert in the antiviral field providing solutions to assist virology and microbiology research, Creative Diagnostics recently introduced Fluorometric Neuraminidase Assay services to the global research community, suitable for functional detection of NI-resistant viruses in mixed virus... - October 23, 2022 - Creative Diagnostics
Biolexis Therapeutics Announces Launch of FIELDS, an AI/ML Drug Discovery Platform
Biolexis is the first company to combine a curated historical wet-lab database, including half-a-million targets of binding data points, with an automated AI/ML-augmented discovery platform. - October 14, 2022 - Biolexis Therapeutics Inc.
Huntington Study Group Enrolls First Participant for Its Observational Study to Test the Reliability of the Virtual Use of the Unified Huntington’s Disease Rating Scale
The Huntington Study Group (HSG), a world leader in conducting clinical trials for Huntington’s Disease (HD) for over 30 years, together with its Clinical Research Organization (“CRO”), the HSG Clinical Research, Inc., today announces the enrollment of the first participant of its... - October 12, 2022 - Huntington Study Group
Mirror Biologics, Inc. Announces Additional $20 Million Investment to Close Out $30 Million Series A Investment Round
Mirror Biologics, Inc., a clinical stage biopharmaceutical company today announced the completion of the final $20 million tranche of its $30 million Series A investment round with Bradbury Asset Management (Hong Kong), Limited. Bradbury provided an initial $10 million tranche for this round in... - October 11, 2022 - Mirror Biologics, Inc.
ALS Therapy Development Institute Announces Superior Rail & Iron Works, Inc. as First Title Sponsor of White Coat Affair Gala
Superior Rail & Iron Works, Inc. will be the first Title Sponsor of the White Coat Affair gala, being held on October 15, 2022, at the Boston Sheraton to raise funds for ALS research. - September 28, 2022 - ALS Therapy Development Institute
Creative Diagnostics Announces the Launch of SARS-CoV-2 ADE Assay
Creative Diagnostics announced the launch of SARS-CoV-2 ADE Assay to support laboratory scientists for SARS-CoV-2 vaccine research. - September 28, 2022 - Creative Diagnostics
New Decentralized Clinical Trial (DCT) Patient Satisfaction and Participation Report
800 Current and Future Clinical Trial Participants Link Satisfaction and Willingness to Participate with Decentralized Strategies - September 21, 2022 - Life Science Strategy Group, LLC
Biomed Industries, Inc. to Acquire MedAware Systems, Inc. to Expand Its Artificial Intelligence Research for Drug Discovery in Alzheimer’s Disease
Biomed Industries, Inc. (“BIOMED” or the “Company”), has entered into a share exchange agreement to acquire all of the issued and outstanding shares of MedAware Systems, Inc. MedAware shares was valued at $1.50 per share and BIOMED’s share was valued at $8.00 per share. The transaction was valued at an aggregate of $18 million, to be paid in the form of 2,259,170 common shares of BIOMED. On the date of the Agreement, BIOMED has approximately 76,354,075 common shares. - September 21, 2022 - Biomed Industries, Inc.
SolarCraft Completes Solar Power Installation for Point Blue Conservation Science in West Marin - Point Reyes Wildlife Institution Increases Sustainability of Operation
Novato and Sonoma-based SolarCraft recently completed the installation of a solar electric power installation at Point Blue Conservation Science Facility in the seaside town Bolinas, West Marin County. Located in the heart of the Point Reyes National Seashore, Point Blue, originally known as the Point Reyes Bird Observatory, is harnessing the power of the sun to provide significant utility savings to their facilities. - September 13, 2022 - SolarCraft
NAMIWalks 2022 Returns to Angels Stadium
The 2022 NAMIWalks Orange County 5K walk will take place at Angels Stadium on November 19, 2022 at 8:00 a.m. Registration will begin at 7:00 a.m. - September 11, 2022 - NAMI Orange County
"Bullying Causes Brain Damage": Science Shows It Can be Reversed, New Book Reveals
Abuse survivor and mother of a bullying victim uncovers latest neuroscience on pervasive societal harm. - September 01, 2022 - Bullied Brain
High-Level Academic and Government Speakers to Present at Military Event in Alexandria, VA
Are you currently an OR Analyst in the field looking to increase your knowledge in leading-edge approaches, methods, and techniques? You do not want to miss the opportunity to participate in this one-of-a-kind Forum highlighting emerging techniques in OR. If you would like to present at the MORS... - August 26, 2022 - MORS
Creative Diagnostics Launches Custom Virus Production Service
Creative Diagnostics has recently introduced the research community with customized virus production services. - August 26, 2022 - Creative Diagnostics
Hadronic Technologies Notes Importance for Environment of 1935 Argument by A. Einstein, B. Podolsky & N. Rosen That "Quantum Mechanics is Not a Complete Theory"
Professor Ruggero Santilli says that new books recently released and the growing importance of a conference in physics and mathematics point to the insufficiency of quantum mechanics for the achievement of new, clean nuclear energies and to the relevance of the EPR completion of quantum into hadronic mechanics to the solution of our increasingly alarming environmental problems. - August 19, 2022 - Hadronic Technologies, Inc.
VMRD Begins Manufacturing Key Reagent for Detection of CWD by RT-QuIC
Veterinary Medical Research & Development (VMRD), Pullman, WA, has partnered with CWD Evolution, Fort Collins, CO, to provide state-of-the-art diagnostic reagents for detection of the abnormal prion associated with Chronic Wasting Disease (CWD). The control of CWD requires identification of... - August 09, 2022 - VMRD, Inc.
Jedsy to Participate at 2022 AACC
Drone delivery made for Laboratories. - July 25, 2022 - Jedsy
Creative Diagnostics Launches Monkeypox Virus Antibodies and Antigens to Support MPXV Research
Creative Diagnostics announced the launch of several Monkeypox Virus Antibodies and Antigens for the detection of Monkeypox viruses. - July 22, 2022 - Creative Diagnostics
PharmStars Announces Spring 2022 Accelerator Graduates: 11 Digital Health Startups Have Successfully Completed PharmStars’ Pharma-Focused Accelerator Program
PharmStars, the pharma-focused accelerator for digital health startups, announces the graduation of 11 startups from its Spring 2022 program. The graduates successfully completed the 10-week PharmaU program, which culminated with the Showcase Event held June 8-10 in Boston. The Showcase Event brought together the participating startups and PharmStars’ seven innovation-minded pharma members. - July 12, 2022 - PharmStars
Immundiagnostik and Preventis GmbH Go Beyond the Lab at the AACC’s Annual Scientific Meeting and Clinical Lab Expo
Immundiagnostik and Preventis GmbH will exhibit together at the upcoming AACC Clinical Lab Expo July 26-28 in Chicago, IL in support of improved patient care. - July 11, 2022 - Immundiagnostik, Inc.
Global Cancer Technology Successfully Concludes Glioblastoma Pre-Clinical Animal Studies with Impressive Results
Global Cancer Technology, a San Diego, CA biotechnology company, has successfully completed animal testing with GCT.GLIO.1, a PI3K selective inhibitor that can cross the blood brain barrier and modulate immune cell function. The company will advance the compound to Phase 1 clinical trials as a next step. - July 08, 2022 - Global Cancer Technology
Scientific Body Type Quiz from Fellow One Research Offers the First-Ever Science-Based Body Type Identification
Scientific Body Type Quiz identifying genetics, diet, exercise, metabolism, lifestyle, fat, and skinny fat as well as vertebrae and muscle development from the global pioneer in Body Type Science (The Four Body Types) successfully clears two years of real-world case study vetting - is ready for widespread public use. - July 02, 2022 - Fellow One Research
Foundation Supporting Indigenous Students to Return a Half-Million Dollars to a Catholic Organization
The Verna J. Kirkness Education Foundation Board Chair, Tony Williams, plans to announce the Board’s decision to return the $500,000 endowment to the Sisters of Saint Anne and terminate the 4.5-year-long relationship. In his announcement, Tony Williams will explain his Board’s decision... - June 24, 2022 - Verna J. Kirkness Foundation
TrialX Launches a DEI Toolkit Within iConnect Platform to Tackle Diversity Challenges in Clinical Trial Recruitment
To overcome barriers to participation of diverse populations in clinical trials, TrialX launches a toolkit for sponsors and sites to create an end to end multilingual experience for patients. - June 21, 2022 - TrialX
Ocean Research Project's Schooner Marie Tharp Stops in Newport Before Ambitious Maiden Voyage to Map Greenland's Uncharted Glacier Fjords
Schooner Marie Tharp stops in Newport area for final preparations before launching into a decadal ocean mapping campaign across the Arctic. Operated by the Ocean Research Project, Marie embarks on her maiden mission to Greenland led by Captain Matt Rutherford and Oceanographer Nicole Trenholm. - June 20, 2022 - Ocean Research Project
Air & Waste Management Association’s Annual Conference Brings Environmental Scientists to San Francisco, June 27-30
The Air & Waste Management Association’s 115th Annual Conference & Exhibition (ACE) will bring together hundreds of environmental professionals from around the world on June 27-30 in San Francisco, CA. This year’s conference on “Science & Sustainable Global... - June 15, 2022 - Air & Waste Management Association
Creative Diagnostics Launches Measles Virus Antigens for the Detection of Antibodies
Creative Diagnostics announced the release of new measles virus antigens suitable for both IgM and IgG detection. - June 11, 2022 - Creative Diagnostics
Eledon Announces Phase 2a Trial Results of Tegoprubart (AT-1501) – a Drug Invented at ALS TDI
Eledon Pharmaceuticals announced topline results from their Phase 2 trial of tegoprubart (formerly AT1501), a drug invented and developed at the ALS Therapy Development Institute (ALS TDI). The Phase 2a trial in ALS was a 12-week, open label, dose escalating, safety, and biomarker study. The... - May 31, 2022 - ALS Therapy Development Institute
Scientific Reports Publishes Data Demonstrating VR Platform Produces Peak Experiences, Ego Attenuation & Connectedness Comparable to Moderate Dose Psychedelics
aNUma, Inc., a digital therapeutics company building virtual reality programs to address the global mental health crisis, today, announced that Scientific Reports has published research demonstrating technology like that behind aNUma’s VR platform can deliver peak experiences, ego attenuation, and connectedness comparable to psychedelics. This study, written by Dr. David Glowacki and colleagues, is the first of its kind to be published in a leading peer-reviewed journal. - May 30, 2022 - aNUma
Creative Diagnostics Launches Antibody-Dependent Enhancement Assay Services
Creative Diagnostics recently introduces comprehensive services for antibody-dependent enhancement (ADE) assay. - May 26, 2022 - Creative Diagnostics